Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G for SAB BIOTHERAPEUTICS, INC. Common Stock, $0.0001 par value per share (SABS).
- Disclosed ownership: 7.3%.
- Date of event: 14 Jan 2026.
PERCEPTIVE ADVISORS LLC - 14 Jan 2026 SCHEDULE 13G Report for SAB BIOTHERAPEUTICS, INC. Common Stock, $0.0001 par value per share (SABS)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- SABS
- Shares outstanding
- 47,559,740 shares
- Disclosed Ownership
- 3,471,861 shares
- Ownership
- 7.3%
- Form type
- SCHEDULE 13G
- Filing time
- 22 Jan 2026, 16:34:06 UTC
- Date of event
- 14 Jan 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 7.3% ownership in SAB BIOTHERAPEUTICS, INC. Common Stock, $0.0001 par value per share (SABS) on 14 Jan 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 22 Jan 2026, 16:34.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 7.3% | 3,471,861 | 0 | 3,471,861 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 7.3% | 3,471,861 | 0 | 3,471,861 | /s/ Joseph Edelman | Joseph Edelman | |
| Perceptive Life Sciences Master Fund, Ltd. | 7.3% | 3,471,861 | 0 | 3,471,861 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |